Robert Schultz-Heienbrok

Company: Xendo Deutchland GmbH
Robert

Robert Schultz-Heienbrok has been educated in medical biology, followed by a PhD in protein biochemistry. He has completed a post-graduate program in Regulatory Affairs and has over 10 years of practical experience in the field. Working both with multinational pharmaceutical companies and small start-ups, Robert has gained broad experience with international submission procedures and dossier requirements for regulatory compliance as well as new market approvals. In 2009 he has been appointed Managing Director of Xendo Deutschland GmbH, a German subsidiary of the Dutch pharmaceutical service company Xendo B.V. His group focuses on regulatory affairs of marketed products, regulatory consultancy for biopharmaceutical developments and regulatory data management.